TY - JOUR
T1 - Cisheteronormativity and its influence on the psychosocial experience of LGBTQ+ people with cancer
T2 - A qualitative systematic review
AU - Franco-Rocha, Oscar Y.
AU - Wheldon, Christopher W.
AU - Osier, Nico
AU - Lett, Elle
AU - Kesler, Shelli R.
AU - Henneghan, Ashley M.
AU - Suárez-Baquero, Daniel Felipe Martín
N1 - Publisher Copyright:
© 2023 John Wiley & Sons Ltd.
PY - 2023/6
Y1 - 2023/6
N2 - Objective: Cisheteronormativity refers to the relationship of heterosexual and cisgender privilege stemming from patriarchy. Although studies have shown that cisheteronormativity can impact health outcomes for lesbian, gay, bisexual, transgender, queer and other sexual, gender diverse, and gender nonconforming (LGBTQ+) people, the specific impact on cancer care has not been described. We synthesized the qualitative evidence on how cisheteronormativity impacts the psychosocial experience of LGBTQ+ people with cancer. Methods: We conducted a historic search in the CINAHL, LGBT+ Health, PsycInfo, and PubMed databases. Qualitative studies that described the psychosocial experience of LGBTQ+ people with cancer were included. After appraising the quality of the publications, 11 articles were included. Then, we conducted inductive nominal coding, taxonomic analysis, and thematic synthesis. Results: Two main themes emerged, (1) Cisheteronormativity as a social determinant of health, and (2) Cancer, sexual orientation, and gender: Associations and introjections. The themes comprise four categories and 13 subcategories that describe the impact of cisheteronormativity on the cancer experience of LGBTQ+ people. Conclusion: Cisheteronormativity within the healthcare system impacts the psychosocial experience of LGBTQ+ people with cancer. Understanding how these gender biases, norms, and social expectations impact the cancer experience is necessary to transform social norms and promote health equity.
AB - Objective: Cisheteronormativity refers to the relationship of heterosexual and cisgender privilege stemming from patriarchy. Although studies have shown that cisheteronormativity can impact health outcomes for lesbian, gay, bisexual, transgender, queer and other sexual, gender diverse, and gender nonconforming (LGBTQ+) people, the specific impact on cancer care has not been described. We synthesized the qualitative evidence on how cisheteronormativity impacts the psychosocial experience of LGBTQ+ people with cancer. Methods: We conducted a historic search in the CINAHL, LGBT+ Health, PsycInfo, and PubMed databases. Qualitative studies that described the psychosocial experience of LGBTQ+ people with cancer were included. After appraising the quality of the publications, 11 articles were included. Then, we conducted inductive nominal coding, taxonomic analysis, and thematic synthesis. Results: Two main themes emerged, (1) Cisheteronormativity as a social determinant of health, and (2) Cancer, sexual orientation, and gender: Associations and introjections. The themes comprise four categories and 13 subcategories that describe the impact of cisheteronormativity on the cancer experience of LGBTQ+ people. Conclusion: Cisheteronormativity within the healthcare system impacts the psychosocial experience of LGBTQ+ people with cancer. Understanding how these gender biases, norms, and social expectations impact the cancer experience is necessary to transform social norms and promote health equity.
KW - cancer
KW - healthcare disparities
KW - oncology
KW - patriarchy
KW - psycho-oncology
KW - review
KW - sexual and gender minorities
KW - Humans
KW - Male
KW - Neoplasms
KW - Gender Identity
KW - Health Promotion
KW - Transgender Persons
KW - Sexual and Gender Minorities
KW - Female
KW - Sexual Behavior/psychology
UR - http://www.scopus.com/inward/record.url?scp=85152271426&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000963450400001&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1002/pon.6133
DO - 10.1002/pon.6133
M3 - Review article
C2 - 37025048
SN - 1057-9249
VL - 32
SP - 834
EP - 845
JO - Psycho-Oncology
JF - Psycho-Oncology
IS - 6
ER -